Sai C. Mullaguri
Hyderabad, TG, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment of K562 Cells with ABL Kinase Inhibitors Reveals Differential Metabolic Profiles.
Journal: Drug research
Published: January 22, 2026
Metabolite profiling identifies upregulation of specific glycerophospholipids and sphingolipids in imatinib-resistant cell lines.
Journal: Biochimica et biophysica acta. General subjects
Published: November 19, 2025
Computational Tools to Analyze the Pathogenicity and Drug Sensitivity of Oncogenic Mutants.
Journal: Current protocols
Published: October 13, 2025
Synthesis of Novel Benazepril-Derived Trizole Compounds Assisted by Ultrasound: In Vitro and In Silico Analysis for Potential Anticancer Properties.
Journal: Chemistry & biodiversity
Published: May 15, 2024
Large-scale pathogenicity prediction analysis of cancer-associated kinase mutations reveals variability in sensitivity and specificity of computational methods.
Journal: Cancer medicine
Published: March 20, 2023
Estimated sensitivity profiles of lung cancer specific uncommon BRAF mutants towards experimental and clinically approved kinase inhibitors.
Journal: Toxicology and applied pharmacology
Published: July 22, 2022
Molecular docking analysis reveals differential binding affinities of multiple classes of selective inhibitors towards cancer-associated KRAS mutants.
Journal: 3 Biotech
Published: January 24, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026